Iovance Biotherapeutics
IOVA
6.90
-0.41
-5.61%
Iovance Biotherapeutics
US · IOVA
#1864 by market cap
Listed 1970
6.90
-0.41
-5.61%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:59
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Goldman Sachs moved from Sell to Buy on 2026-09-24.
Analyst consensus 8 analysts
Buy
Avg price target 16.38 +137.4%
Price target rangecurrent 6.90
Low11.00
Avg16.38
High20.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-11-06 | Citizens JMP | -- | Buy | 12.00 |
| 2026-11-06 | Barclays | -- | Buy | 19.00 |
| 2026-11-05 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-10-29 | Wells Fargo | -- | Buy | 18.00 |
| 2026-10-29 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-10-29 | Barclays | -- | Buy | 18.00 |
| 2026-10-27 | Barclays | -- | Buy | 18.00 |
| 2026-10-26 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-10-23 | Jefferies | -- | Buy | 20.00 |
| 2026-10-13 | Barclays | -- | Buy | 18.00 |
| 2026-10-12 | Jefferies | -- | Buy | 20.00 |
| 2026-09-30 | Wells Fargo | -- | Buy | 18.00 |
| 2026-09-30 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-09-29 | TD Cowen | -- | Buy | 16.00 |
| 2026-09-29 | Wells Fargo | -- | Buy | 18.00 |
| 2026-09-29 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-09-29 | Barclays | -- | Buy | 15.00 |
| 2026-09-24 | Goldman Sachs | -- | Buy | 15.00 |
| 2026-09-17 | Barclays | -- | Buy | 15.00 |
| 2026-08-25 | TD Cowen | -- | Buy | 10.00 |
| 2026-08-17 | Mizuho Securities | -- | Buy | 11.00 |
| 2026-08-07 | Citizens JMP | -- | Buy | 8.00 |
| 2026-08-07 | Barclays | -- | Buy | 13.00 |
| 2026-08-06 | H.C. Wainwright | -- | Buy | 9.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-24 | Goldman Sachs | Sell → Buy | 15.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | -- | ±12.73% | -11.03% (in line) |
| 2026/Q2 | 2026-08-06 | -- | ±29.65% | +43.09% (beat) |
| 2026/Q1 | 2026-05-07 | -- | ±15.83% | -13.20% (in line) |
| 2025/Q4 | 2026-02-24 | -- | ±18.34% | +30.80% (beat) |
| 2025/Q3 | 2025-11-06 | -- | ±24.86% | +27.62% (beat) |
| 2025/Q2 | 2025-08-07 | After close | ±34.92% | -20.08% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±27.44% | -44.80% (beat) |
| 2024/Q4 | 2025-02-27 | After close | ±25.10% | -19.49% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±19.14% | -13.80% (in line) |
| 2024/Q2 | 2024-08-08 | After close | ±29.91% | +24.94% (in line) |
| 2024/Q1 | 2024-05-09 | After close | ±17.71% | -18.48% (beat) |
| 2023/Q4 | 2024-02-28 | After close | ±11.80% | -8.72% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:59:47 · For reference only, not investment advice and not tailored to your situation.
Iovance Biotherapeutics discussion 0 comments